NUAK2 and hepatocellular carcinoma: As we recently reported that SNARK enhanced TGF-β signaling in HCC cells and the pharmacological inhibition of SNARK resulted in the suppression of profibrogenic signaling [9], the effects of DSF were next assessed in cell culture.